Abstract
Objective: The aim of this study was to assess the effects of fish oil supplementation in pregnancy on maternal erythrocyte fatty acid composition at different stages of pregnancy and in the post-partum period, and on neonatal erythrocyte fatty acid composition.
Design: A double-blind, randomised, placebo-controlled study.
Setting: Subiaco, Western Australia.
Subjects: In all, 98 women booked for delivery at St John of God Hospital, Subiaco, were recruited from private rooms of obstetricians. In total, 83 women and their healthy full-term babies completed the study.
Interventions: Women received either 4 g of fish oil (n=52) (56% docosahexaenoic acid (DHA) and 28% eicosapentaenoic acid (EPA) or placebo (olive oil) (n=46) per day from 20 weeks gestation until delivery.
Main outcome measures: Erythrocyte phospholipid fatty acids were measured in maternal peripheral blood at 20, 30 and 37 weeks of pregnancy and at 6 weeks post partum, and from cord blood collected at birth.
Results: Compared to the control group, maternal EPA and DHA were significantly higher in the fish oil group at 30 and 37 weeks gestation, and remained elevated at 6 weeks post partum (P<0.001). The proportions of n-6 polyunsaturated (arachidonic acid, 22:3n-6 and 22:4n-6) were significantly lower in the fish oil supplemented group at the same time periods (P<0.001). Similarly, the proportions of EPA and DHA were significantly higher (P<0.001), and those of n-6 polyunsaturated fatty acids arachidonic acid, 20:3n-6, 22:3n-6 and 22:4n-6 were significantly lower (P<0.001), in erythrocytes from neonates in the fish oil group, compared to those in the control group.
Conclusions: Fish oil supplementation from 20 weeks of pregnancy until birth is an effective means of enhancing n-3 fatty acid status of both mothers and neonates. Furthermore, the changes in maternal erythrocyte fatty acid composition are retained until at least 6 weeks post partum. It is essential to assess the effects of concomitant decreases in arachidonic acid status before any dietary recommendations can be made.
Sponsorship: The study was supported by grants from the NH & MRC and Raine Medical Research Foundation, Australia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Al MD, Hornstra G, van der Schouw YT, Bulstra-Ramakers MT & Huisjes HJ (1990): Biochemical EFA status of mothers and their neonates after normal pregnancy. Early Hum. Dev. 24, 239–248.
Al MD, van Houwelingen AC & Hornstra G (2000): Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am. J. Clin. Nutr. 71, 285S–291S.
Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE & Hornstra G (1995a): Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br. J. Nutr. 74, 55–68.
Al MD, von Houwelingen AC, Badart-Smook A & Hornstra G (1995b): Some aspects of neonatal essential fatty acid status are altered by linoleic acid supplementation of women during pregnancy. J. Nutr. 125, 2822–2830.
Black PN & Sharpe S (1997): Dietary fat and asthma: is there a connection? Eur. Respir. J. 10, 6–12.
Borod E, Atkinson R, Barclay WR & Carlson SE (1999): Effects of third trimester consumption of eggs high in docosahexaenoic acid on docosahexaenoic acid status and pregnancy. Lipids 34, S231.
Carlson SE (1999): Long-chain polyunsaturated fatty acids and development of human infants. Acta Paediatr. Suppl. 88, 72–77.
Carlson SE, Ford AJ, Werkman SH, Peeples JM & Koo WW (1996): Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatr. Res. 39, 882–888.
Carlson SE & Neuringer M (1999): Polyunsaturated fatty acid status and neurodevelopment: a summary and critical analysis of the literature. Lipids 34, 171–178.
Carlson SE, Werkman SH, Peeples JM, Cooke RJ & Tolley EA (1993): Arachidonic acid status correlates with first year growth in preterm infants. Proc. Natl. Acad. Sci. USA 90, 1073–1077.
Carlson SE, Werkman SH, Peeples JM & Wilson WM (1994): Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur. J. Clin. Nutr. 48(Suppl 2), S27–S30.
Clandinin MT (1999): Brain development and assessing the supply of polyunsaturated fatty acid. Lipids 34, 131–137.
Clandinin MT, Chappell JE, Heim T, Swyer PR & Chance GW (1981): Fatty acid accretion in foetal and neonatal liver: implications for fatty acid requirements. Early Hum. Dev. 5, 7–14.
Connor WE (2000): Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71, 171S–175S.
Connor WE, Lowensohn R & Hatcher L (1996): Increased docosahexaenoic acid levels in human newborn infants by administration of sardines and fish oil during pregnancy. Lipids 31 (Suppl), S183–S187.
Crawford M (2000): Placental delivery of arachidonic and docosahexaenoic acids: implications for the lipid nutrition of preterm infants. Am. J. Clin. Nutr. 71, 275S–284S.
CSIRO Division of Human Nutrition (1996): CSIRO Australian Food and Nutrition Surveys 1988 & 1993: Results from the CSIRO Australian Food and Nutrition Surveys 1988 and 1993. Adelaide, SA: CSIRO, Division of Human Nutrition.
Dutta-Roy AK (2000): Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. Cell. Mol. Life Sci. 57, 1360–1372.
Elias SL & Innis SM (2001): Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am. J. Clin. Nutr. 73, 807–814.
Garg ML, Thomson AB & Clandinin MT (1990): Interactions of saturated, n-6 and n-3 polyunsaturated fatty acids to modulate arachidonic acid metabolism. J. Lipid Res. 31, 271–277.
Gerrard J, Popeski D, Ebbeling L, Brown P & Hornstra G (1991): Dietary omega 3 fatty acids and gestational hypertension in the Inuit. Arctic Med. Res. (Suppl), 763–767.
Gibson RA, Chen W & Makrides M (2001): Randomized trials with polyunsaturated fatty acid interventions in preterm and term infants: functional and clinical outcomes. Lipids 36, 873–883.
Gibson RA & Makrides M (1999): Polyunsaturated fatty acids and infant visual development: a critical appraisal of randomized clinical trials. Lipids 34, 179–184.
Gibson RA, Neumann MA & Makrides M (1997): Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur. J. Clin. Nutr. 51, 578–584.
Haggarty P, Page K, Abramovich DR, Ashton J & Brown D (1997): Long-chain polyunsaturated fatty acid transport across the perfused human placenta. Placenta 18, 635–642.
Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T & Drevon CA (2001): Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108, E82.
Hodge L, Salome CM, Peat JK, Haby MM, Xuan W & Woolcock AJ (1996): Consumption of oily fish and childhood asthma risk [see comments]. Med. J. Aust. 164, 137–140.
Innis SM (1991): Essential fatty acids in growth and development. Prog. Lipid Res. 30, 39–103.
Knopp RH (1991): Lipid metabolism in pregnancy. In Principles of Perinatal-neonatal Metabolism, ed. RM Cowett, pp 177–203. New York: Springer-Verlag.
Koletzko B & Braun M (1991): Arachidonic acid and early human growth: is there a relation? Ann. Nutr. Metab. 35, 128–131.
Makrides M & Gibson RA (2000): Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. Am. J. Clin. Nutr. 71, 307S–311S.
Makrides M, Simmer K, Neumann M & Gibson R (1995): Changes in the polyunsaturated fatty acids of breast milk from mothers of full-term infants over 30 wk of lactation. Am. J. Clin. Nutr. 61, 1231–1233.
Matorras R, Perteagudo L, Sanjurjo P & Ruiz JI (1999): Intake of long chain w3 polyunsaturated fatty acids during pregnancy and the influence of levels in the mother on newborn levels. Eur. J. Obstet. Gynecol. Reprod. Biol. 83, 179–184.
Matorras R, Ruiz JI, Perteagudo L, Barbazan MJ, Diaz A, Valladolid A & Sanjurjo P (2001): Longitudinal study of fatty acids in plasma and erythrocyte phospholipids during pregnancy. J. Perinat. Med. 29, 293–297.
Minda H, Larque E, Koletzko B & Decsi T (2002): Systematic review of fatty acid composition of plasma phospholipids of venous cord blood in full-term infants. Eur. J. Nutr. 41, 125–131.
Mori TA, Beilin LJ, Burke V, Morris, J & Ritchie, J . (1997): Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 17, 279–286.
Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD & Beilin LJ (2000): Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 71, 1085–1094.
Neuringer M, Connor WE, Van Petten C & Barstad L (1984): Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J. Clin. Invest. 73, 272–276.
Olsen SF, Hansen HS, Sandstrom B & Jensen B (1995): Erythrocyte levels compared with reported dietary intake of marine n-3 fatty acids in pregnant women. Br. J. Nutr. 73, 387–395.
Olsen SF, Soorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS & Grant A (1994): Fish oil supplementation and duration of pregnancy. A randomized controlled trial. Ugeskr. Laeger. 156, 1302–1307.
Olsen SF, Sorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS & Grant A (1992): Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 339, 1003–1007.
Onwude JL, Lilford RJ, Hjartardottir H, Staines, A & Tuffnell D (1995): A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br. J. Obstet. Gynaecol. 102, 95–100.
Otto SJ, Houwelingen AC, Antal M, Manninen A, Godfrey K, Lopez-Jaramillo P & Hornstra G (1997): Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur. J. Clin. Nutr. 51, 232–242.
Otto SJ, van Houwelingen AC, Badart-Smook A & Hornstra G (1999): The postpartum docosahexaenoic acid status of lactating and nonlactating mothers. Lipids 34, S227.
Otto SJ, van Houwelingen AC, Badart-Smook A & Hornstra G (2001): Comparison of the peripartum and postpartum phospholipid polyunsaturated fatty acid profiles of lactating and nonlactating women. Am. J. Clin. Nutr. 73, 1074–1079.
Otto SJ, van Houwelingen AC & Hornstra G (2000): The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester. Prostaglandins Leukot. Essent. Fatty Acids 63, 323–328.
Salvig JD, Olsen SF & Secher NJ (1996): Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. Br. J. Obstet. Gynaecol. 103, 529–533.
Simopoulos AP (1999): Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr. 70, 560S–569S.
Sprecher H (2000): Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta 1486, 219–231.
van Houwelingen AC, Ham EC & Hornstra G (1999): The female docosahexaenoic acid status related to the number of completed pregnancies. Lipids 34, S229.
van Houwelingen AC, Pul J & Hornstra G (1992): Essential fatty acid status during early human development. Early Hum. Dev. 31, 97–111.
van Houwelingen AC, Sorensen JD, Hornstra G, Simonis MM, Boris J, Olsen SF & Secher NJ (1995): Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. Br. J. Nutr. 74, 723–731.
Velzing-Aarts FV, van der Klis FR, van der Dijs FP, van Beusekom CM, Landman H, Capello JJ & Muskiet FA (2001): Effect of three low-dose fish oil supplements, administered during pregnancy, on neonatal long-chain polyunsaturated fatty acid status at birth. Prostaglandins Leukot. Essent. Fatty Acids 65, 51–57.
Woltil HA, van Beusekom CM, Schaafsma A, Muskiet FA & Okken A (1998): Long-chain polyunsaturated fatty acid status and early growth of low birth weight infants. Eur. J. Pediatr. 157, 146–152.
Yaqoob P, Knapper JA, Webb DH, Williams CM, Newsholme EA & Calder PC (1998): Effect of olive oil on immune function in middle-aged men. Am. J. Clin. Nutr. 67, 129–135
Acknowledgements
We wish to acknowledge the staff and patients who assisted us in this study. We are particularly grateful to the obstetricians and midwives at St John of God Hospital, Subiaco, Western Australia. We thank Professor Scott Weiss, Harvard Medical School for his role in the planning and design of this study. We also wish to thank Ms Lynette McCahon for technical assistance, Ms Elaine Pascoe for statistical advice and Dr Thierry Venaille for his advice and support during the study design. The study was supported by grants from the NH & MRC and Raine Medical Research Foundation, Australia.
Author information
Authors and Affiliations
Contributions
Guarantor: SL Prescott was accountable for all parts of the completed manuscript before and after publication.
Contributors J A Dunstan—study design, collection and analysis of data, writing the manuscript. T A Mori, Anne Barden, Lawrie Beilin—study design, collection of data, writing the manuscript. P G Holt—significant advice and consultation on study design; significant consultation on collection of data. P Calder—significant advice and consultation on study design; writing the manuscript. A L Taylor—collection of data. S L Prescott—senior author responsible for study design; collection and analysis of data; writing the manuscript.
Corresponding author
Rights and permissions
About this article
Cite this article
Dunstan, J., Mori, T., Barden, A. et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 58, 429–437 (2004). https://doi.org/10.1038/sj.ejcn.1601825
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601825
Keywords
This article is cited by
-
Impact of n-3 polyunsaturated fatty acid intake in pregnancy on maternal health and birth outcomes: systematic review and meta-analysis from randomized controlled trails
Archives of Gynecology and Obstetrics (2022)
-
Influence of cafeteria diet and fish oil in pregnancy and lactation on pups’ body weight and fatty acid profiles in rats
European Journal of Nutrition (2016)
-
Effect of dietary intervention to reduce the n-6/n-3 fatty acid ratio on maternal and fetal fatty acid profile and its relation to offspring growth and body composition at 1 year of age
European Journal of Clinical Nutrition (2013)